Literature DB >> 17570244

The cytoprotective effect of alpha-tocopherol and daidzein against d-galactosamine-induced oxidative damage in the rat liver.

Max C Y Wong1, Bernard Portmann, Roy Sherwood, Onni Niemela, Heidi Koivisto, Seppo Parkkila, Keith Trick, Mary R L'abbe, James Wilson, Philip R Dash, Raj Srirajaskanthan, Victor R Preedy, Helen Wiseman.   

Abstract

We hypothesized that the hepatotoxicity that develops after the induction of oxidative stress (induced by d-galactosamine [GalN]) can be ameliorated by alpha-tocopherol (ATC) and the soy isoflavone daidzein. To test this, we ranked and assigned male Wistar rats into 6 groups, which involved pretreatment (ATC or daidzein) for 1 hour followed by treatment (GalN) for 23 hours. Histopathologic analysis showed that GalN administration induced marked necrosis (P < .001), steatosis (P < .001), both lobular and portal inflammations (P < .001), overall histopathologic score (P < .001), and activation of caspase-3 in the liver (P < .001). Immunohistochemical staining of malondialdehyde-protein adducts, a measure of oxidative stress, was increased in response to GalN (P < .001). Paradoxically, there were increases in total (P < .05) and cytosolic superoxide dismutase (P < .001) activities after GalN administration, indicative of an up-regulation of antioxidant defenses. The concentration of total protein (P < .001), albumin (P < .01), and globulin fractions (P < .001) in the plasma, as well as the activity of aspartate aminotransferase (P < .001), was significantly perturbed after GalN treatment, reflective of overall acute hepatic injury. Administration of daidzein showed a significant amelioration of the Ga1N-induced increase in malondialdehyde-protein adducts (P < .01) and cytosolic superoxide dismutase activities (P < .01) in the liver. However, all other variables were not significantly altered in response to daidzein. In response to ATC pretreatment, the total histopathologic score (P < .05), degree of necrosis (P < .05), and both lobular (P < .05) and portal (P = .05) inflammations were significantly ameliorated. To conclude, both daidzein and ATC protect the liver against oxidative damage possibly via different pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570244     DOI: 10.1016/j.metabol.2007.01.005

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

Review 1.  A review on the role of nutraceuticals as simple as se(2+) to complex organic molecules such as glycyrrhizin that prevent as well as cure diseases.

Authors:  Regi Jose; G R Sajitha; K T Augusti
Journal:  Indian J Clin Biochem       Date:  2013-07-23

2.  Exploratory Studies of (-)-Epicatechin, a Bioactive Compound of Phyllanthus niruri, on the Antioxidant Enzymes and Oxidative Stress Markers in D-galactosamine-induced Hepatitis in Rats: A Study with Reference to Clinical Prospective.

Authors:  Bhasha Shanmugam; Kondeti Ramudu Shanmugam; Sahukari Ravi; Ganjikunta Venkata Subbaiah; Chilakala Ramakrishana; Korivi Mallikarjuna; Kesireddy Sathyavelu Reddy
Journal:  Pharmacogn Mag       Date:  2017-04-07       Impact factor: 1.085

3.  Effect of daidzein on cisplatin-induced hematotoxicity and hepatotoxicity in experimental rats.

Authors:  Sanjiv Karale; Jagadish Vasudev Kamath
Journal:  Indian J Pharmacol       Date:  2017 Jan-Feb       Impact factor: 1.200

4.  Exploring the In Vivo Existence Forms (23 Original Constituents and 147 Metabolites) of Astragali Radix Total Flavonoids and Their Distributions in Rats Using HPLC-DAD-ESI-IT-TOF-MSn.

Authors:  Li-Jia Liu; Hong-Fu Li; Feng Xu; Hong-Yan Wang; Yi-Fan Zhang; Guang-Xue Liu; Ming-Ying Shang; Xuan Wang; Shao-Qing Cai
Journal:  Molecules       Date:  2020-11-26       Impact factor: 4.411

Review 5.  Protective effect of isoflavones and triterpenoid saponins from pueraria lobata on liver diseases: A review.

Authors:  Heng He; Shuwei Peng; Xu Song; Renyong Jia; Yuanfeng Zou; Lixia Li; Zhongqiong Yin
Journal:  Food Sci Nutr       Date:  2021-12-10       Impact factor: 2.863

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.